The Indiana University Cognitive Health Outcomes Investigation of the Comparative Effectiveness of dementia screening (CHOICE) study: study protocol for a randomized controlled trial

Trials

Malaz A Boustani³  Dustin D French¹  Greg A Sachs³  Christopher M Callahan³  Sujuan Gao³  Anthony J Perkins⁴  Amie Frame⁴  Amanda Harrawood⁴  Nicole R Fowler² 

[1] Center for Healthcare Studies and Department of Ophthalmology Northwestern University Feinberg School of Medicine, 420 East Superior Street, 60611 Chicago, IL, USA;Department of Medicine, University of Pittsburgh, 200 Meyran Avenue Suite 300, 15215 Pittsburgh, PA, USA;Department of Biostatistics, Indiana University School of Medicine, 410 West 10th Street Suite 3000, 46202 Indianapolis, IN, USA;Regenstrief Institute, Inc., 410 West 10th Street Suite 2000, 46202 Indianapolis, IN, USA

关键词: Primary care;    Dementia;    Dementia screening;    Alzheimer’s disease;   

Others  :  805240
DOI  :  10.1186/1745-6215-15-209

 received in 2014-01-17, accepted in 2014-05-21,  发布年份 2014

【 摘 要 】

Background

Dementia affects over 4 million people in the US and is frequently unrecognized and underdiagnosed in primary care. Routine dementia screening in primary care is not recommended by the US Preventive Services Task Force due to lack of empirical data on the benefits and harms of screening. This trial seeks to fill this gap and contribute information about the benefits, harms, and costs of routine screening for dementia in primary care.

Methods/Design

Single-blinded, parallel, randomized controlled clinical trial with 1:1 allocation. A total of 4,000 individuals aged ≥65 years without a diagnosis of dementia, cognitive impairment, or serious mental illness receiving care at primary care practices within two cities in Indiana. Subjects will be randomized to either i) screening for dementia using the Memory Impairment Screen Telephone version or ii) no screening for dementia. Subjects who screen positive for dementia will be referred to the local Aging Brain Care program that delivers an evidence-based collaborative care model for dementia and depression. Research assistants will administer the 15-item Health Utility Index, Patient Health Questionnaire, Generalized Anxiety Disorder Scale, and Medical Outcomes Study at baseline, 1, 6, and 12 months. Information about advanced care planning will be collected at baseline and 12 months. All enrollees’ medical records will be reviewed to collect data on health care utilization and costs.

Discussion

We have two primary hypotheses; first, in comparison to non-screened subjects, those who are screened and referred to a dementia collaborative care program will have a higher health-related quality of life as measured by the Health Utility Index at 12 months post-screening. Second, in comparison to non-screened subjects, those who are screened and referred to a dementia collaborative care program will not have higher depression or anxiety at one month post-screening as measured by the Patient Health Questionnaire and Generalized Anxiety Disorder Scale scales. Our secondary hypothesis is that screened subjects will have an Incremental Cost-Effectiveness Ratio below the maximum acceptable threshold of $60,000 per quality adjusted life year saved at 12 months.

Trial registration

Ongoing; registered on September 19, 2012. ClinicalTrials.gov Identifier: 2012 NCT01699503.

【 授权许可】

   
2014 Fowler et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

【 参考文献 】

• [1]Plassman BL, Langa KM, Fisher GG, Heeringa SG, Weir DR, Ofstedal MB, Burke JR, Hurd MD, Potter GG, Rodgers WL, Steffens DC, Willis RJ, Wallace RB: Prevalence of dementia in the United States: the aging, demographics, and memory study. Neuroepidemiology 2007, 29:125-132.
• [2]Hebert LE, Scherr PA, Bienias JL, Evans DA: Alzheimer disease in the US population: prevalence estimates using the 2000 census. Arch Neurol 2003, 60(8):1119-1122.
• [3]Association A’s: 2012 Alzheimer’s disease facts and figures. Alzheimers Dement 2012, 8(2):131-168.
• [4]Boustani M, Callahan CM, Unverzagt FW, Austrom MG, Perkins AJ, Fultz BA, Hui SL, Hendrie HC: Implementing a screening and diagnosis program for dementia in primary care. J Gen Intern Med 2005, 20(7):572-577.
• [5]Borson S, Frank L, Bayley PJ, Boustani M, Dean M, Lin PJ, McCarten JR, Morris JC, Salmon DP, Schmitt FA, Stefanacci RG, Mendiondo MS, Peschin S, Hall EJ, Fillit H, Ashford JW: Improving dementia care: the role of screening and detection of cognitive impairment. Alzheimers Dement 2013, 9(2):151-159.
• [6]Ashford JW, Borson S, O’Hara R, Dash P, Frank L, Robert P, Shankle WR, Tierney MC, Henry Brodaty H, Schmitt FA, Kraemer HC, Buschke H, Fillit H: Should older adults be screened for dementia? It is important to screen for evidence of dementia! Alzheimers Dement 2007, 3(2):75-80.
• [7]Boustani M, Peterson B, Hanson L, Harris R, Lohr KN, U.S. Preventive Services Task Force: Screening for dementia in primary care: a summary of the evidence for the U.S. preventive services task force. Ann Intern Med 2003, 138(11):927-937.
• [8]Lin J, O’Connor E, Rossom RC, Perdue LA, Eckstrom E: Screening for cognitive impairment in older adults: a systematic review for the U.S. preventive services task force. Ann Intern Med 2013, 159(9):601-612.
• [9]Cordell CB, Borson S, Boustani M, Chodosh J, Reuben D, Verghese J, Thies W, Fried LB: Alzheimer’s Association recommendation for operationalizing the detection of cognitive impairment during the medicare annual wellness visit in a primary care setting. Alzheimers Dement 2013, 9(2):141-150.
• [10]Boustani M, Sachs GA, Alder CA, Munger S, Schubert CC, Austrom MG, Hake A, Unverzagt FW, Farlow M, Matthews BR, Perkins AJ, Beck RA, Callahan CM: Implementing innovative models of dementia care: the healthy aging brain center. Aging Ment Health 2011, 15(1):13-22.
• [11]Callahan CM, Boustani MA, Weiner M, Beck RA, Livin LR, Kellams JJ, Willis DR, Hendrie HC: Implementing dementia care models in primary care settings: the aging brain care medical home. Aging Ment Health 2011, 15(1):5-12.
• [12]Chan DC, Kasper JD, Black BS, Rabins PV: Presence of behavioral and psychological symptoms predicts nursing home placement in community-dwelling elders with cognitive impairment in univariate but not multivariate analysis. J Gerontol A Biol Sci Med Sci 2003, 58(6):548-554.
• [13]Counsell SR, Callahan CM, Buttar AB, Clark DO, Frank KI: Geriatric Resources for Assessment and Care of Elders (GRACE): a new model of primary care for low-income seniors. J Am Geriatr Soc 2006, 54(7):1136-1141.
• [14]Lipton RB, Katz MJ, Kuslansky G, Sliwinski MJ, Stewart WF, Verghese J, Crystal HA, Buschke H: Screening for dementia by telephone using the memory impairment screen. J Am Geriatr Soc 2003, 51(10):1382-1390.
• [15]Brodaty H, Low LF, Gibson L, Burns K: What is the best dementia screening instrument for general practitioners to use? Am J Geriatr Psychiatry 2006, 14(5):391-400.
• [16]McCarten JR, Anderson P, Kuskowski MA, McPherson SE, Borson S, Dysken MW: Finding dementia in primary care: the results of a clinical demonstration project. J Am Geriatr Soc 2012, 60(2):210-217.
• [17]McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack CR Jr, Kawas CH, Klunk WE, Koroshetz WJ, Manly JJ, Mayeux R, Mohs RC, Morris JC, Rossor MN, Scheltens P, Carrillo MC, Thies B, Weintraub S, Phelps CH: The diagnosis of dementia due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement 2011, 7(3):263-269.
• [18]Callahan CM, Boustani M, Unverzagt FW, Austrom MG, Damush TM, Perkins AJ, Fultz BA, Hui SL, Counsell SR, Hendrie HC: Effectiveness of collaborative care for older adults with Alzheimer disease in primary care: a randomized controlled trial. JAMA 2006, 295(18):2148-2157.
• [19]Austrom MG, Damush TM, Hartwell CW, Perkins A, Unverzagt F, Boustani M, Hendrie HC, Callahan CM: Development and implementation of nonpharmacologic protocols for the management of patients with Alzheimer’s disease and their families in a multiracial primary care setting. Gerontologist 2004, 44(4):548-553.
• [20]Horsman J, Furlong W, Feeny D, Torrance G: The Health Utilities Index (HUI): concepts, measurement properties and applications. Health Qual Life Outcomes 2003, 1:54. BioMed Central Full Text
• [21]Kavirajan H, Hays RD, Vassar S, Vickrey BG: Responsiveness and construct validity of the health utilities index in patients with dementia. Med Care 2009, 47(6):651-661.
• [22]Naglie G, Tomlinson G, Tansey C, Irvine J, Ritvo P, Black SE, Freedman M, Silberfeld M, Krahn M: Utility-based quality of life measures in Alzheimer’s disease. Qual Life Res 2006, 15(4):631-643.
• [23]Vickrey BG, Mittman BS, Connor KI, Pearson ML, Della Penna RD, Ganiats TG, Demonte RW, Chodosh J, Cui X, Vassar S, Duan N, Lee ML: The effect of a disease management intervention on quality and outcomes of dementia care: a randomized, controlled trial. Ann Int Med 2006, 145(10):713-726.
• [24]Kroenke K, Spitzer RL, Williams JB: The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med 2001, 16(9):606-613.
• [25]Kroenke K, Spitzer RL: The PHQ-9: a new depression and diagnostic severity measure. Psychiatr Ann 2002, 32:509-521.
• [26]Spitzer RL, Kroenke K, Williams JB, Lowe B: A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med 2006, 166(10):1092-1097.
• [27]Kroenke K, Spitzer RL, Williams JB, Monahan PO, Löwe B: Anxiety disorders in primary care: prevalence, impairment, comorbidity, and detection. Ann Intern Med 2007, 146(5):317-325.
• [28]Little RJA, Rubin DB: Statistical Analysis with Missing Data. New York: Wiley; 1987.
• [29]Johannesson M, Jonsson B, Jonsson L, Kobelt G, Zethraeus N: Why Should Economic Evaluations of Medical Innovations have a Societal Perspective?. London: Office of Health Economics Briefing No. 51; 2009. http://www.ohe.org webcite
• [30]Etzioni R, Urban N, Baker M: Estimating the costs attributable to a disease with application to ovarian cancer. J Clin Epidemiol 1996, 49(1):95-103.
• [31]Manning W, Fryback DG, Weinstein MC: Reflecting uncertainty in cost-effectiveness analysis. In Cost-Effectiveness in Health and Medicine. Edited by Gold M, Siegel J, Russell L, Weinstein M. New York: Oxford University Press; 1996.
• [32]Garber AM, Phelps CE: Economic foundations of cost-effectiveness analysis. J Health Econ 1997, 16(1):1-31.
• [33]Hoch JS, Briggs AH, Willan AR: Something old, something new, something borrowed, something blue: a framework for the marriage of health econometrics and cost-effectiveness analysis. Health Econ 2002, 11:415-430.
• [34]Boustani MA, Jemoumi R, Munger S: Forecasting the future impact of early detection and management Program for Alzheimer disease. Am J Geriatr Psychiatr 2009, 17:A9-A149.
• [35]Boustani M, Sachs G, Callahan CM: Can primary care meet the biopsychosocial needs of older adults with dementia? J Gen Intern Med 2007, 22(11):1625-1627.
• [36]Schubert CC, Boustani M, Callahan CM, Perkins AJ, Carney CP, Fox C, Unverzagt F, Hui S, Hendrie HC: Comorbidity profile of dementia patients in primary care: are they sicker? J Am Geriatr Soc 2006, 54(1):104-109.
• [37]Callahan CM, Hendrie HC, Tierney WM: Documentation and evaluation of cognitive impairment in elderly primary care patients. Ann Int Med 1995, 122(6):422-429.
• [38]Di Santo SG, Prinelli F, Adorni F, Caltagirone C, Musicco M: A meta-analysis of the efficacy of donepezil, rivastigmine, galantamine, and memantine in relation to severity of Alzheimer’s disease. J Alzheimers Dis 2013, 35(2):349-361.
• [39]Reisberg B, Doody R, Stoffer A, Schmitt F, Ferris S, Möbius HJ, Memantine Study Group: Memantine in moderate-to-severe Alzheimer’s disease. N Engl J Med 2003, 348(14):1333-1341.
• [40]Pitkälä KH, Pöysti MM, Laakkonen M, Tilvis RS, Savikko N, Kautiainen H, Strandberg TE: Effects of the Finnish Alzheimer Disease Exercise Trial (FINALEX): a randomized controlled trial. JAMA Intern Med 2013, 173(10):894-901.
• [41]Boustani M, Perkins AJ, Monahan P, Fox C, Watson L, Hopkins J, Fultz B, Hui S, Unverzagt FW, Callahan CM, Hendrie HC: Measuring primary care patients’ attitudes about dementia screening. Int J Geriatr Psychiatry 2008, 23(8):812-820.
• [42]Fowler NR, Boustani M, Frame A, Perkins AJ, Monahan P, Gao S, Sachs GA, Hendrie H: Impact of patients’ perceptions on dementia screening in primary care. J Am Geriatr Soc 2012, 60(6):1037-1043.
• [43]Simmons BB, Dejoseph D: Evaluation of suspected dementia. Am Fam Physician 2011, 84(8):895-902.
• [44]Reuben D, Roth CP, Frank JC, Hirsch SH, Katz D, McCreath H, Younger J, Murawski M, Edgerly E, Maher J, Maslow K, Wenger NW: Assessing care of vulnerable elders–Alzheimer’s disease: a pilot study of a practice redesign intervention to improve the quality of dementia care. J Am Geriat Soc 2010, 58(2):324-329.